aspartic acid has been researched along with Drug Withdrawal Symptoms in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.00) | 18.7374 |
| 1990's | 9 (36.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baandrup, L; Ebdrup, BH; Glenthøj, BY; Gluud, C; Lindschou, J; Rasmussen, JØ | 1 |
| Fischer, KD; Houston, AC; Rebec, GV | 1 |
| Morgenstern, R; Netzhammer, N; Seidemann, T; Spies, C; Wernecke, KD | 1 |
| Demirakca, T; Dieter, S; Ende, G; Falfan-Melgoza, C; Frischknecht, U; Hermann, D; Kiefer, F; Krumm, B; Mann, KF; Sack, M; Sommer, WH; Spanagel, R; Tunc-Skarka, N; van Eijk, J; Wang, GY; Weber-Fahr, W | 1 |
| Adalsteinsson, E; Flynn, N; Galloway, GP; Gibson, DR; Leamon, M; Nordahl, TE; Pfefferbaum, A; Possin, K; Salo, R; Spielman, DM; Sullivan, EV | 1 |
| Minami, M; Nakagawa, T; Ozawa, T; Satoh, M; Sekiya, Y | 1 |
| Kendig, JJ; Peters, MC; Sweitzer, SM; Wong, SME | 1 |
| Buonocore, MH; Galloway, GP; Kile, S; Moore, CD; Natsuaki, Y; Nordahl, TE; Salo, R; Waters, C | 1 |
| Aghajanian, GK; Kogan, JH; Moghaddam, B | 1 |
| Feng, Y; Ho, IK; Rockhold, RW; Zhang, T | 1 |
| Ho, IK; Hoshi, K; Ma, T | 1 |
| Contreras, E; Hernandez, L; Rada, P; Sepulveda, MJ; Tucci, S | 1 |
| Chang, R; Chen, S; Coyle, JT; Linnoila, VM; Ragan, P; Tsai, GE | 1 |
| Hanin, I; Kindel, G; Wülfert, E; Zhang, X | 1 |
| Chen, JC; Chiang, YC; Huang, YK; Liang, CS; Liang, KW | 1 |
| Nakagawa, T | 1 |
| Favalli, L; Frattini, P; Govoni, S; Masoero, E; Pascale, A; Rozza, A; Scelsi, R | 1 |
| Eroğlu, L; Güngör, M; Koyuncuoğlu, H; Sağduyu, H | 1 |
| Ariciŏglu, F; Dizdar, Y; Esin, Y; Koyuncuŏglu, H; Uresin, Y | 1 |
| Little, HJ | 1 |
| Aricioğlu, F; Güngör, M; Koyuncuoğlu, H; Sağduyu, H | 1 |
| McCaslin, PP; Morgan, WW | 2 |
| Ceylan, ME; Koyuncuoğlu, H; Sener, AI | 1 |
| Harris, RL; Hawkins, RA; Miller, AL; Veech, RL | 1 |
3 review(s) available for aspartic acid and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.
Topics: Adult; Antidepressive Agents; Aspartic Acid; Benzodiazepines; Buspirone; Carbamazepine; Ethylamines; Flumazenil; Homeopathy; Humans; Imidazoles; Lithium Compounds; Melatonin; Paroxetine; Pregabalin; Progesterone; Pyridines; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Sulfides; Withholding Treatment | 2018 |
[Involvement of glial glutamate transporters in morphine dependence and naloxone-precipitated withdrawal].
Topics: Amino Acid Transport System X-AG; Animals; Aspartic Acid; Astrocytes; Brain; Cells, Cultured; Excitatory Amino Acid Transporter 2; Gene Expression; Humans; Morphine Dependence; Naloxone; RNA, Messenger; Substance Withdrawal Syndrome | 2001 |
Mechanisms that may underlie the behavioural effects of ethanol.
Topics: Alcoholic Intoxication; Animals; Aspartic Acid; Behavior; Behavior, Animal; Calcium; Calcium Channels; Cell Membrane; Dihydropyridines; Drug Tolerance; Ethanol; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Ion Channel Gating; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Synaptic Transmission | 1991 |
1 trial(s) available for aspartic acid and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Comparison of the suppressive effects of L-aspartic acid and chlorpromazine + diazepam treatments on opiate abstinence syndrome signs in men.
Topics: Aspartic Acid; Chlorpromazine; Diazepam; Drug Therapy, Combination; Humans; Male; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1986 |
21 other study(ies) available for aspartic acid and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Role of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior.
Topics: Analysis of Variance; Animals; Aspartic Acid; Behavior, Animal; Blotting, Western; Ceftriaxone; Cocaine-Related Disorders; Conditioning, Operant; Cues; Excitatory Amino Acid Transporter 2; Feeding Behavior; Kainic Acid; Male; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Recurrence; Substance Withdrawal Syndrome | 2013 |
Influence of Volatile Anesthesia on the Release of Glutamate and other Amino Acids in the Nucleus Accumbens in a Rat Model of Alcohol Withdrawal: A Pilot Study.
Topics: Amino Acids; Anesthesia, Inhalation; Animals; Arginine; Aspartic Acid; Desflurane; Disease Models, Animal; Feeding Behavior; gamma-Aminobutyric Acid; Glutamic Acid; Isoflurane; Male; Microdialysis; Nucleus Accumbens; Pilot Projects; Rats, Wistar; Substance Withdrawal Syndrome; Time Factors; Volatilization | 2017 |
Negative Association Between MR-Spectroscopic Glutamate Markers and Gray Matter Volume After Alcohol Withdrawal in the Hippocampus: A Translational Study in Humans and Rats.
Topics: Adult; Alcohol Abstinence; Alcoholism; Animals; Aspartic Acid; Biomarkers; Female; Glutamic Acid; Gray Matter; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Rats; Rats, Wistar; Species Specificity; Substance Withdrawal Syndrome; Translational Research, Biomedical | 2017 |
Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy.
Topics: Adult; Age Factors; Amphetamine-Related Disorders; Aspartic Acid; Choline; Creatine; Dopamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Neurons; Serotonin; Substance Withdrawal Syndrome; Visual Cortex | 2002 |
Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate in rats.
Topics: Amino Acid Transport System X-AG; Animals; Aspartic Acid; Conditioning, Operant; Male; Morphine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2004 |
Hyperresponsiveness on washout of volatile anesthetics from isolated spinal cord compared to withdrawal from ethanol.
Topics: Anesthetics, Inhalation; Animals; Aspartic Acid; Bronchial Hyperreactivity; Calcitonin Gene-Related Peptide; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Electric Stimulation; Enzyme Inhibitors; Ethanol; Excitatory Postsynaptic Potentials; Glutamic Acid; Indoles; Maleimides; Protein Kinase C; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P; Substance Withdrawal Syndrome | 2005 |
Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Topics: Adult; Ambulatory Care; Amphetamine-Related Disorders; Aspartic Acid; Brain; Choline; Creatine; Dopamine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Phosphocreatine; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Tissue Distribution; Visual Cortex | 2005 |
Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study.
Topics: Animals; Aspartic Acid; Drug Implants; Extracellular Space; Glutamates; Glutamic Acid; Locus Coeruleus; Male; Microdialysis; Morphine; Naloxone; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1994 |
Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.
Topics: Animals; Aspartic Acid; Dialysis; Drug Interactions; Glutamates; Glutamic Acid; Locus Coeruleus; Male; Morphine; Naloxone; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1994 |
Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
Topics: Analgesics; Analysis of Variance; Animals; Aspartic Acid; Benzeneacetamides; Butorphanol; Glutamic Acid; Injections, Intraventricular; Locus Coeruleus; Male; Microdialysis; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1996 |
Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study.
Topics: Animals; Aspartic Acid; Calcium; Extracellular Space; Glutamic Acid; Male; Microdialysis; Morphine; Naloxone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1998 |
Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal.
Topics: Adult; Alcoholism; Aspartic Acid; Dipeptides; Ethanol; Excitatory Amino Acids; Female; gamma-Aminobutyric Acid; Glutamates; Humans; Male; Middle Aged; Oxidative Stress; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Superoxide Dismutase; Synaptic Transmission; Up-Regulation | 1998 |
Mivazerol inhibits intrathecal release of glutamate evoked by halothane withdrawal in rats.
Topics: Adrenergic alpha-Agonists; Anesthesia; Anesthetics, Inhalation; Animals; Aspartic Acid; Blood Pressure; Glutamic Acid; Halothane; Heart Rate; Imidazoles; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance Withdrawal Syndrome | 1998 |
Significance of glutamate and dopamine neurons in the ventral pallidum in the expression of behavioral sensitization to amphetamine.
Topics: Amphetamine; Animals; Aspartic Acid; Behavior, Animal; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Globus Pallidus; Glutamic Acid; Male; Motor Activity; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2001 |
Ischemia-induced glutamate release in rat frontoparietal cortex after chronic alcohol and withdrawal.
Topics: Alcoholism; Animals; Aspartic Acid; Central Nervous System Depressants; Dialysis Solutions; Ethanol; Glutamic Acid; Ischemic Attack, Transient; Male; Microdialysis; Parietal Lobe; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2002 |
The antagonizing effect of aspartic acid on morphine withdrawal and levallorphan-precipitated abstinence syndrome signs and on associated changes in brain levels of free amino acids in the rat.
Topics: Amino Acids; Animals; Aspartic Acid; Body Weight; Brain Chemistry; Humans; Levallorphan; Motor Activity; Rats; Substance Withdrawal Syndrome; Time Factors | 1979 |
Effects of tizanidine on morphine physical dependence: attenuation and intensification.
Topics: Adrenergic alpha-Agonists; Analgesics; Animals; Aspartic Acid; Behavior, Animal; Clonidine; Glutamates; Glutamic Acid; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine Dependence; Muscle Contraction; Muscle, Smooth; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1992 |
Intensification and attenuation of morphine dependence by D-aspartic acid and PLG.
Topics: Animals; Asparaginase; Aspartic Acid; Brain; Mice; Mice, Inbred BALB C; Morphine Dependence; MSH Release-Inhibiting Hormone; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1990 |
Increased response of cerebellar cGMP to kainate but not NMDA or quisqualate following barbital withdrawal from dependent rats.
Topics: Animals; Aspartic Acid; Barbital; Barbiturates; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Female; Injections, Intraventricular; Kainic Acid; N-Methylaspartate; Neuromuscular Depolarizing Agents; Oxadiazoles; Quisqualic Acid; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Aspartic Acid; Barbital; Barbiturates; Cerebellum; Cyclic GMP; Female; N-Methylaspartate; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1987 |
The effects of acute and chronic morphine treatment and of morphine withdrawal on rat brain in vivo.
Topics: Acetazolamide; Adenosine Diphosphate; Adenosine Triphosphate; Ammonia; Animals; Arteries; Aspartic Acid; Brain; Carbon Dioxide; Citrates; Glucose; Glutarates; Humans; Hydrogen-Ion Concentration; Lactates; Malates; Male; Morphine; Morphine Dependence; Nalorphine; Phosphocreatine; Pyruvates; Rats; Substance Withdrawal Syndrome | 1972 |